Kirkuk University Journal-Scientific Studies

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Indexing and Abstracting

Related Links

Peer Review Process

News

Authorship

Copyright Policies

Determination of some hematological, biochemical parameters and vitamin D receptor gene polymorphism in Kurdish patients with COVID-19 in Erbil city

    Authors

    1 Department of Biology, College of Education, Salahaddin University, Erbil, Iraq.

    2 Depatment of Biology, College of Education, University of Salahaddin, Erbil, Iraq.

,

Document Type : Research Paper

Abstract

Coronavirus infection a new infectious illness brought on by the SARS-COV-2 virus has infected people worldwide as of 2019, a covid-19 disease is associated with hematological and biochemical parameters changes. The present study aimed to evaluate the possible relationship between patient parameters and disease severity. A total of 200 nasopharyngeal swabs and whole blood specimens were collected from individuals suspected of CoV-2 and healthy volunteers as control of both sexes, grouped into four groups:50 patients for each mild, moderate, and severe patients and 50 healthy volunteers. The current study demonstrated that female 82(55%) was more frequently affected than male 68(45%). Hematological parameters including white blood cell count (WBC), granulocyte count, and Red blood cell distribution width (RDW%) (increased significantly p < 0.05, while Lymphocyte count decreased significantly when compared with a control group. Significant differences in hemoglobin concentration, packed cell volume, red blood cell count, and indices of red blood cell count were shown when compared with a control group in both sexes. Regarding biochemical parameters including serum vitamin D, ferritin, D-dimer, procalcitonin (PCT), and liver function tests, serum vitamin D decreased significantly, while serum ferritin, D-dimer, procalcitonin and liver enzymes increased significantly in the covid-19 patients group compared to the control group. According to vitamin D receptor ,gene polymorphism in covid-19 patients genotype Bb was most likely associated and strongly related to getting infected with CoV-2 virus with all the three known stages of infection.Severity of CoV-2 was associated with leukocytosis, lymphopenia and biomarkers are the best predictors of severe CoV-2, with a strong relation of VDR gene polymorphism BsmI with the severity of CoV-2 patients

Keywords

Main Subjects

References
[1] Organization WH., interim guidance. World Health Organization, 2020.
[2] II. Bogoch, A. Watts, A. Thomas-Bachli, C. Huber, MU. Kraemer, and K. Khan. Pneumonia of unknown aetiology in wuhan, china: potential for international spread via commercial air travel. Journal of travel medicine, 27(2):taaa008, 2020, doi:10.1093/jtm/taaa008.
[3] B. Abdulqadir Ali. Epidemiological approach of sarscov2 in the first month of appearance in the kurdistan region of iraq. European Journal of Molecular Clinical
Medicine, 7(11): 2853–65, 2020.
[4] Organization WH., Living guideline, Retrieved. World Health Organization, 2023.
[5] M. Narasimhan JM. Crawford T. McGinn KW. Davidson S. Richardson, JS. Hirsch and et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the new york city area. Journal of the American Medical Association, 323(20): 2052–9, 2020, doi:10.1001/jama.2020.6775.
[6] G. Grasselli, A. Zangrillo, A. Zanella, M. Antonelli, L. Cabrini, A. Castelli, and et al. Baseline characteristics and outcomes of 1591 patients infected with sars-cov-2
admitted to icus of the lombardy region, italy. Journal of the American Medical Association, 323(16): 1574–81, 2020, doi:10.1001/jama.2020.5394.
[7] A. Khalid, M. Ali Jaffar, T. Khan, R. Abbas Lail, S. Ali, G. Aktas, and et al. Hematological and biochemical parameters as diagnostic and prognostic markers in sarscov-2 infected patients of pakistan: a retrospective comparative analysis. Hematology, 26(1): 529–42, 2021, doi:10.1080/16078454.2021.1950898.
[8] C. Qin, L. Zhou, Z. Hu, S. Zhang, S. Yang, Y. Tao, and et al. Dysregulation of immune response in patients with coronavirus 2019 (covid-19) in wuhan, china. clinical infectious diseases. An official publication of the Infectious Diseases Society of America, 71(15): 762–8, 2020, doi:10.1093/cid/ciaa248.
[9] B. Zhu, X. Feng, C. Jiang, S. Mi, L. Yang, Z. Zhao, and et al. Correlation between white blood cell count at admission and mortality in covid-19 patients: a retrospective study. BMC infectious diseases, 21(1): 574, 2021, doi:10.1186/s12879-021-06277-3.
[10] S. Jandaghian, A. Vaezi, A. Manteghinejad, M. Nasirian, G. Vaseghi, and S. Haghjooy Javanmard. Red blood cell distribution width (rdw) as a predictor of in hospital mortality in covid-19 patients; a cross sectional study Archives of academic emergency medicine, 9(1): e67, 2021, doi:10.22037/aaem.v9i1.1325.
[11] D. Bikle. Nonclassic actions of vitamin d. The Journal of clinical endocrinology and metabolism, 94(1): 26–34, 2009, doi:10.1210/jc.2008-1454.
[12] HA. Dissanayake, NL. de Silva, M. Sumanatilleke, SDN. de Silva, Gamage, C. Dematapitiya, and et al. Prognostic and therapeutic role of vitamin d in covid-19: Systematic review and meta-analysis. The Journal of Clinical Endocrinology Metabolism, 107(5): 1484–502, 2022, doi:10.1210/clinem/dgab892.
[13] R. Ghasemian, A. Shamshirian, K. Heydari, M. Malekan, R. Alizadeh-Navaei, MA. Ebrahimzadeh, and et al. The role of vitamin d in the age of covid-19: A systematic review and meta-analysis. International journal of clinical practice, 75(11): e14675, 2021, doi:10.1111/ijcp.14675.
[14] M. Pereira, A. Dantas Damascena, LM. Galvao Azevedo, ˜T. de Almeida Oliveira, and J. da Mota Santana. Vitamin d deficiency aggravates covid-19: systematic review and meta-analysis. Critical reviews in food science and nutrition, 62(5): 1308–16, 2022, doi:10.1080/10408398.2020.1841090.
[15] S. Zelzer, F. Pruller, P. Curcic, Z. Sloup, M. Holter, ¨M. Herrmann, and et al. metabolites and clinical outcome in hospitalized covid-19 patients. Nutrients, 13(7): 2129, 2021, doi:10.3390/nu13072129.
[16] V. Contreras-Bol´ıvar, B. Garc´ıa-Fontana, C. Garc´ıaFontana, and M. Munoz Torres. Vitamin d and covid-19: ˜where are we now? Postgraduate Medicine, 1-13, 2021, doi:10.1080/00325481.2021.2017647.
[17] K. Kaushal, H. Kaur, Sarma, A. Bhattacharyya, DJ. Sharma, M.Prajapat, and et al. Serum ferritin as a predictive biomarker in covid-19. a systematic review, metaanalysis and meta-regression analysis. Journal of critical care, 67: 172–81, 2022, doi: 10.1016/j.jcrc.2021.09.023.
[18] P. Mehta, DF. McAuley, M. Brown, E. Sanchez, RS. Tattersall, and JJ. Manson. Covid-19: consider cytokine storm syndromes and immunosuppression. The lancet, 395(10229): 1033–4, 2020, doi: 10.1016/S0140-6736(20)30628-0.
[19] S. Shah, K. Shah, SB. Patel, FS. Patel, M. Osman, P. Velagapudi, and et al. Elevated d-dimer levels are associated with increased risk of mortality in coronavirus disease 2019: A systematic review and meta-analysis. Cardiology in Review, 28(6).
[20] A. Farasani. Biochemical role of serum ferratin and d-dimer parameters in covid 19 diagnosis. Saudi journal of biological sciences, 28(12): 7486–90, 2021, doi: 10.1016/j.sjbs.2021.08.040.
[21] J. Thachil, M. Cushman, A. Srivastava, and P. Angchaisuksiri. A proposal for staging covid19 coagulopathy. Research and practice in thrombosis and haemostasis, 4(5): 731–6, 2020, doi: 10.1002/rth2.12372.
[22] C. Vanhomwegen, I. Veliziotis, S. Malinverni, D. Konopnicki, P. Dechamps, M. Claus, and et al. Procalcitonin accurately predicts mortality but not bacterial infection in covid-19 patients admitted to intensive care unit. Irish Journal of Medical Science, 190(4): 1649–52, 2021, doi:10.1007/s11845-020-02485-z.
[23] JB. Xu, C. Xu, RB. Zhang, M. Wu, CK. Pan, XJ. Li, and et al. Associations of procalcitonin, c-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized covid-19 patients in china. Scientific reports, 10(1): 15058, 2020, doi:10.1038/s41598-020-72164-7.
[24] WJ. Guan, WH. Liang, Y. Zhao, HR. Liang, ZS. Chen, YM. Li, and et al. Comorbidity and its impact on 1590 patients with covid-19 in china: a nationwide analysis. The European respiratory journal, 55(5).
[25] MN. Bangash, J. Patel, and D. Parekh. Covid-19 and the liver: little cause for concern. The lancet Gastroenterology hepatology, 20205(6): 529–30, 2020, doi: 10.1016/S2468-1253(20)30084-4.
[26] PP. Bloom, EA. Meyerowitz, Z. Reinus, M. Daidone, J. Gustafson, AY. Kim, and et al. Liver biochemistries in hospitalized patients with covid-19. Hepatology, 73(3): 890–900, 2021, doi: 10.1002/hep.31326.
[27] Y. Li, Y. Hu, J. Yu, and T. Ma. Retrospective analysis of laboratory testing in 54 patients with severe- or criticaltype 2019 novel coronavirus pneumonia. Laboratory Investigation, 100(6): 794–800, 2020, doi: 10.1038/s41374-020-0431-6.
[28] Q. Cai, D. Huang, H. Yu, Z. Zhu, Z. Xia, Y. Su, and et al. Covid-19: Abnormal liver function tests. Journal of Hepatology, 73(3): 566–74, 2020, doi:10.1016/j.jhep.2020.04.006.
[29] H. Zhang, H. Han, T. He, KE. Labbe, AV. Hernandez, H. Chen, and et al. Clinical characteristics and outcomes of covid-19–infected cancer patients: a systematic review and meta-analysis. Journal of the National Cancer Institute, 113(4): 371–80, 2021, doi:10.1093/jnci/djaa168.
[30] S. Zheng, J. Yang, X. Hu, M. Li, Q. Wang, RCA. Dancer, and et al. Vitamin d attenuates lung injury via stimulating epithelial repair, reducing epithelial cell apoptosis and inhibits tgf-β induced epithelial to mesenchymal transition. Biochemical Pharmacology, 177: 113955, 2020, doi:10.1016/j.bcp.2020.113955.
[31] K. Baynes, B. Boucher, E. Feskens, and D. Kromhout. Vitamin d, glucose tolerance and insulinaemia in elderly men. Diabetologia, 40(3): 344–7, 1997, doi:10.1007/s001250050685.
[32] S. Raimondi, E. Pasquali, P. Gnagnarella, D. Serrano, D. Disalvatore, HA. Johansson, and et al. Bsmi polymorphism of vitamin d receptor gene and cancer risk: a comprehensive meta-analysis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 769: 17–34, 2014, doi:10.1016/j.mrfmmm.2014.06.001.
[33] KA. Maulood. Estimation of vitamin d receptor gene polymorphism in type 2 diabetes mellitus patients in erbil city. Cellular and Molecular Biology, 67(3): 76–84, 2021, doi:10.14715/cmb/2021.67.3.10.
[34] H. A. Dissanayake, N. L. De Silva, M. Sumanatilleke, S. D. N. De Silva, K. K. K. Gamage, C. Dematapitiya, D. C. Kuruppu, P. Ranasinghe, S. Pathmanathan, and P. Katulanda. Prognostic and therapeutic role of vitamin d in covid-19: Systematic review and meta-analysis. The Journal Of Clinical Endocrinology Metabolism, 107: 1484–1502, 2022, doi:10.1210/Clinem/Dgab892.
[35] R. Abdollahzadeh, MH. Shushizadeh, M. Barazandehrokh, S. Choopani, A. Azarnezhad, S. Paknahad, and et al. Association of vitamin d receptor gene polymorphisms and clinical/severe outcomes of covid-19 patients. infection. Genetics and Evolution, 96: 105098, 2021, doi:10.1210/Clinem/Dgab892.
[36] D. Akdogan, M. Guzel, D. Tosun, and O. Akpinar. Diagnostic and early prognostic value of serum crp and ldh levels in patients with possible covid-19 at the first admission. The Journal of Infection in Developing Countries, 15(06): 766–72, 2021, doi:10.3855/jidc.14072.
[37] T. Wiggill, E. Mayne, J. Vaughan, and S. Louw. Overview of the haematological effects of covid-19 infection. Clinical, Biological and Molecular Aspects of COVID-19, 163-72.
[38] L. Tan, Q. Wang, D. Zhang, J. Ding, Q. Huang, Y-Q. Tang, and et al. Lymphopenia predicts disease severity of covid-19: a descriptive and predictive study. Signal transduction and targeted therapy, 5(1): 1–3, 2020, doi:10.1038/s41392-020-0148-4.
[39] X. Yang, Y. Yu, J. Xu, H. Shu, H. Liu, Y. Wu, and et al. Clinical course and outcomes of critically ill patients with sars-cov-2 pneumonia in wuhan, china: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine, 8(5): 475–81, 2020, doi:10.1016/S2213-2600(20)30079-5.
[40] H. Xu, L. Zhong, J. Deng, J. Peng, H. Dan, X. Zeng, and et al. High expression of ace2 receptor of 2019-ncov on the epithelial cells of oral mucosa. International journal of oral science, 12(1): 1–5, 2020, doi:10.1038/s41368-020-0074-x.
[41] IA. I. Abdullah and ZC. ZC Chapanduka. The pathophysiology of the haematological manifestations of covid-19: a review. The Journal of Medical Laboratory Science and Technology of South Africa, 2(2): 54–8, 2020.
[42] B. Bai, Z. Xu, Y. Hu, M. Qu, J. Cheng, S. Luo, and et al. Patient hematology during hospitalization for viral pneumonia caused by sars-cov-2 and non-sars-cov-2 agents: a retrospective study. European Journal of Medical Research, 26(1): 1–11, 2021, doi:10.1186/s40001-021-00515-9.
[43] M. Alshahawey, M. Raslan, and N. Sabri. Sex-mediated effects of ace2 and tmprss2 on the incidence and severity of covid-19; the need for genetic implementation. Current Research in Translational Medicine, 68(4): 149–50, 2020,
doi:10.1016/j.retram.2020.08.002.
[44] A. D’Avolio, V. Avataneo, A. Manca, J. Cusato, A. De Nicolo, R. Lucchini, and et al. 25-hydroxyvitamin `d concentrations are lower in patients with positive pcr for sars-cov-2. Nutrients, 12(5): 1359, 2020, doi:10.3390/nu12051359.
[45] A. Alunno, F. Carubbi, and J. Rodr´ıguez-Carrio. Storm, typhoon, cyclone or hurricane in patients with covid19? beware of the same storm that has a different origin. Rheumatic Musculskeletal Diseases, 6(1): e001295, 2020, doi:10.1136/rmdopen-2020-001295.
[46] I. Huang, R. Pranata, MA. Lim, A. Oehadian, and B. Alisjahbana. C-reactive protein, procalcitonin, d-dimer, and ferritin in severe coronavirus disease2019: a meta-analysis. Therapeutic advances in respiratory disease, 14: 1753466620937175, 2020, doi:10.1177/1753466620937175.
[47] Y. Yao, J. Cao, Q. Wang, Q. Shi, K. Liu, Z. Luo, and et al. D-dimer as a biomarker for disease severity and mortality in covid-19 patients: a case control study. Journal of intensive care, 8(1): 1–11, 2020, doi:10.1186/s40560-020-00466-z.
[48] D. Agnes, LYC. JM, L. Kreuziger, M. Murphy, T. Gernsheimer, Y. Lin, and et al. Covid-19 and coagulopathy: frequently asked questions. American Society of Hematology, COVID-19 Resources COVID-19 and Coagulopathy Version, 7.
[49] BS. Joly, V. Siguret, and A. Veyradier. Understanding pathophysiology of hemostasis disorders in critically ill patients with covid-19. Intensive care medicine, 46(8): 1603–6, 2020, doi:10.1007/s00134-020-06088-1.
[50] B. Mouhat, M. Besutti, K. Bouiller, F. Grillet, C. Monnin, F. Ecarnot, and et al. Elevated d-dimers and lack of anticoagulation predict pe in severe covid-19 patients. European Respiratory Journal, 56(4).
[51] S. Ventura-D´ıaz, JV. Quintana-Perez, A. Gil-Boronat, ´M. Herrero-Huertas, L. Gorospe-Sarasua, J. Montilla, ´and et al. A higher d-dimer threshold for predicting pulmonary embolism in patients with covid-19: a retrospective study. Emergency Radiology, 27(6): 679–89, 2020, doi:10.1007/s10140-020-01859-1.
[52] SE. Johnson, E. Pai, A. Voroba, NW. Chen, and A. Bahl. Examining d-dimer and empiric anti-coagulation in covid19-related thrombosis. Cureus, 14(7): e26883, 2022, doi:10.7759/cureus.26883.
[53] W j. Guan, Z y. Ni, Y. Hu, W h. Liang, C q. Ou, J x. He, and et al. Clinical characteristics of coronavirus disease 2019 in china. New England journal of medicine, 382(18): 1708–20, 2020, doi:10.1056/NEJMoa2002032.
[54] J. Thachil, N. Tang, S. Gando, A. Falanga, Cattaneo, M. Levi, and et al. Isth interim guidance on recognition and management of coagulopathy in covid-19. Journal of Thrombosis and Haemostasis, 18(5): 1023–6, 2020,
doi:10.1111/jth.14810.
[55] JJ. Choi and MW. McCarthy. Novel applications for serum procalcitonin testing in clinical practice. Expert Review of Molecular Diagnostics, 18(1): 27–34, 2018, doi:10.1080/14737159.2018.1407244.
[56] A. Rodr´ıguez, LF. Reyes, J. Monclou, B. Suberviola, M. Bod´ı, G. Sirgo, and et al. Relationship between acute kidney injury and serum procalcitonin (pct) concentration in critically ill patients with influenza infection. Medicina Intensiva, 42(7): 399–408, 2018, doi:10.1016/j.medin.2017.12.004.
[57] JJ. Zhang, X. Dong, YY. Cao, YD. Yuan, YB. Yang, YQ. Yan, and et al. Clinical characteristics of 140 patients infected with sars-cov-2 in wuhan, china. Allergy, 75(7): 1730–41, 2020, doi:10.1111/all.14238.
[58] A. Kumar, E. Karn, K. Trivedi, P. Kumar, G. Chauhan, A. Kumari, and et al. Procalcitonin as a predictive marker in covid-19: A systematic review and meta-analysis. PloS one, 17(9): e0272840, 2022, doi:: 10.1371/journal.pone.0272840.
[59] S. Gautam, AJ. Cohen, Y. Stahl, P. Valda Toro, GM. Young, R. Datta, and et al. Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia. Thorax, 75(11): 974, 2020, doi:10.1136/thoraxjnl-2020-214896.
[60] Y. Shen, C. Cheng, X. Zheng, Y. Jin, G. Duan, M. Chen, and et al. Elevated procalcitonin is positively associated with the severity of covid-19: A meta-analysis based on 10 cohort studies. Medicina, 57(6): 594, 2021, doi:10.3390/medicina57060594.
[61] A. Bertolini, IP. van de Peppel, FA. Bodewes, H. Moshage, A. Fantin, F. Farinati, and et al. Abnormal liver function tests in patients with covid-19: relevance and potential pathogenesis. Hepatology, 72(5): 1864–72, 2020, doi:10.1002/hep.31480.
[62] Y. Wang, S. Liu, H. Liu, W. Li, F. Lin, L. Jiang, and et al. Sars-cov-2 infection of the liver directly contributes to hepatic impairment in patients with covid19. Journal of hepatology, 2020;73(4): 807–16, 2020, doi:10.1016/j.jhep.2020.05.002.
[63] F. Zhou, T. Yu, R. Du, G. Fan, Y. Liu, Z. Liu, and et al. Clinical course and risk factors for mortality of adult inpatients with covid-19 in wuhan, china: a retrospective cohort study. The lancet, 395(10229): 1054–62, 2020, doi:10.1016/S0140-6736(20)30566-3.
[64] Z. Fan, L. Chen, J. Li, X. Cheng, J. Yang, C. Tian, and et al. Clinical features of covid-19-related liver functional abnormality. Clinical Gastroenterology and Hepatology, 18(7): 1561–6, 2020, doi:10.1016/j.cgh.2020.04.002.
[65] H-Y. Lei, Y-H. Ding, K. Nie, Y-M. Dong, JH. Xu, M-L. Yang, and et al. Potential effects of sars-cov-2 on the gastrointestinal tract and liver. Biomedicine Pharmacotherapy, 133: 111064, 2021, doi:10.1016/j.biopha.2020.111064.
[66] MN. Bangash, JM. Patel, D. Parekh, N. Murphy, RM. Brown, AM. Elsharkawy, and et al. Sars-cov2: Is the liver merely a bystander to severe disease? Journal of Hepatology, 73(4): 995–6, 2020, doi:10.1016/j.jhep.2020.05.035.
Kirkuk University Journal-Scientific Studies

Articles in Press, Accepted Manuscript
Available Online from 30 June 2023
Files
Share
Export Citation
Statistics